CSIMarket Company Name, Ticker, Suppliers, else..


Biogen Inc   (BIIB)
Other Ticker:  
 

Biogen Inc

BIIB's Fundamental analysis



Biogen Inc 's sales fell by -2.72 % in I. Quarter 2023 from the same quarter a year ago. Ranking at No. 131

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -12.77 %

Biogen Inc 's net income grew by 77.39 % in I. Quarter 2023 year on year, above company average,

• More on BIIB's Growth


Biogen Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Biogen Inc PEG ratio is at 0.12 Biogen Inc realized cash outflow of $ -3.73per share in trailing twelve-month period.
Company
14.01
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 4.34.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.99.


• More on BIIB's Valuation
 
 Total Debt (Millions $) 6,283
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,051,467
 Net Income/Employee (TTM) $ 325,775
 Receivable Turnover (TTM) 6.24
 Tangible Book Value (Per Share $) 42.85

Biogen Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Biogen Inc PEG ratio is at 0.12 Biogen Inc realized cash outflow of $ -3.73per share in trailing twelve-month period.
Company
14.01
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 4.34.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.99.

Biogen Inc Price to Book Ratio is at 3.18 lower than Indusry Avg. of 4.21. and lower than S&P 500 Avg. of 1354.72

• More on BIIB's Valuation

•  Market Capitalization (Millions $) 43,902
•  Shares Outstanding (Millions) 145
•  Employees 9,610
•  Revenues (TTM) (Millions $) 10,105
•  Net Income (TTM) (Millions $) 3,131
•  Cash Flow (TTM) (Millions $) -541
•  Capital Exp. (TTM) (Millions $) -227
•  Total Debt (Millions $) 6,283
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 1,051,467
•  Net Income/Employee(TTM) $ 325,775
•  Receivable Turnover Ratio (TTM) 6.24
•  Tangible Book Value (Per Share $) 42.85

•  Market Capitalization (Millions $) 43,902
•  Shares Outstanding (Millions) 145
•  Employees 9,610
•  Revenues (TTM) (Millions $) 10,105
•  Net Income (TTM) (Millions $) 3,131
•  Cash Flow (TTM) (Millions $) -541
•  Capital Exp. (TTM) (Millions $) -227


    BIIB's Profitability Comparisons
Biogen Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2023 to 20.61 % from 28.18 % in IV. Quarter.

Biogen Inc net profit margin of 15.74 % is currently ranking no. 19 in Biotechnology & Pharmaceuticals industry, ranking no. 60 in Healthcare sector and number 913 in S&P 500.


Profitability by Segment



  Ratio
•   Capital Ratio (MRQ) 3.24
•  Total Debt to Equity (MRQ) 0.46
•  Tangible Leverage Ratio (MRQ) 1.74
•  Asset Turnover Ratio (TTM) 0.4
•  Inventory Turnover Ratio (TTM) 1.65



Biogen Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2023 to 20.61 % from 28.18 % in IV. Quarter.

Biogen Inc net profit margin of 15.74 % is currently ranking no. 19 in Biotechnology & Pharmaceuticals industry, ranking no. 60 in Healthcare sector and number 913 in S&P 500.

• More on BIIB's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071